ArticleJournal of medical case reports2026
Short-term sacral neuromodulation sustained long-term efficacy in the management of postoperative urinary retention after pelvic surgery: a case report.
Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundSacral neuromodulation (SNM) serves as an effective therapeutic option for lower urinary tract dysfunction, and long-term intervention is generally required to sustain clinical benefits. Reports regarding durable therapeutic outcomes achieved with short-term SNM remain uncommon. This case indicates that short-term SNM can bring about sustained improvement of refractory non-obstructive voiding dysfunction after resection of large pelvic teratoma. CASE PRESENTATION: A 19-year-old female developed refractory urinary retention following excision of a huge mature cystic teratoma of the pelvis measuring 12.3 × 12.3 × 9.6 cm. Conventional conservative treatment for three months failed to relieve her symptoms. Urodynamics demonstrated reduced bladder capacity, hypersensitivity, late-filling uninhibited detrusor contractions, and a flattened voiding flow curve, with a post-void residual urine volume of 1020 mL. The patient underwent one-stage sacral neuromodulation implantation at the left S3 nerve root, with stimulation parameters set at 14 Hz, 0.6 mV and 200 μs. Spontaneous micturition returned on the first postoperative day with a single voided volume over 100 mL. During the initial six postoperative days, the average voided volume was 245 ± 76 mL, and the average daily voiding frequency was 5.5 ± 1.5 episodes. No recurrence of voiding dysfunction was observed after deactivating the stimulator. One-month urodynamic studies showed improvements in bladder capacity, though maximum flow rate remained low under study conditions. However, following stimulator deactivation, objective real-life data including a 6-day voiding diary confirmed excellent spontaneous voiding (253 mL/void, 4.5 times/day) with a post-void residual of 0 mL, showing no recurrence during the six-month follow-up.
conclusionsThis case suggests that short-term sacral neuromodulation can exert rapid and long-lasting effects on bladder dysfunction secondary to pelvic nerve injury, which may help reconstruct the micturition reflex and improve bladder function. The therapeutic effect could be well maintained after stimulation discontinuation and electrode removal, and no recurrence of dysuria was noted within the six-month follow-up period. This observation provides a novel reference for the treatment strategy and duration of SNM in managing urinary retention. Nevertheless, its definitive efficacy still requires verification through more clinical cases and prolonged follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.